Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1996 2
1998 2
2000 2
2001 2
2002 1
2003 1
2004 1
2005 4
2006 1
2007 1
2010 1
2011 1
2012 2
2013 3
2014 2
2015 4
2016 3
2017 5
2018 5
2019 2
2020 5
2021 5
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Malignant Pleural Effusions: Updates in Diagnosis and Management.
Hughes SM, Carmichael JJ. Hughes SM, et al. Life (Basel). 2022 Dec 31;13(1):115. doi: 10.3390/life13010115. Life (Basel). 2022. PMID: 36676064 Free PMC article. Review.
Malignant pleural effusions remain a significant clinical problem resulting in greater than 125,000 hospitalizations per year and leading to over 5 billion dollars in healthcare utilization costs. Not only are health care expenditures related to malignant …
Malignant pleural effusions remain a significant clinical problem resulting in greater than 125,000 hospitalizations per year …
Healthcare Costs and Utilization among Patients Hospitalized for Malignant Pleural Effusion.
Shafiq M, Ma X, Taghizadeh N, Kharrazi H, Feller-Kopman DJ, Tremblay A, Yarmus LB. Shafiq M, et al. Respiration. 2020;99(3):257-263. doi: 10.1159/000506210. Epub 2020 Mar 10. Respiration. 2020. PMID: 32155630
BACKGROUND: Malignant pleural effusion (MPE) poses a considerable healthcare burden, but little is known about trends in directly attributable hospital utilization. ...METHODS: We analyzed adult hospitalizations attributable to MPE using the Healthcare Cost a …
BACKGROUND: Malignant pleural effusion (MPE) poses a considerable healthcare burden, but little is known about trends i …
Management of malignant pleural effusion in Italian clinical practice: a nationwide survey.
Mei F, Tamburrini M, Gonnelli F, Morandi L, Bonifazi M, Sediari M, Berardino ADM, Barisione E, Failla G, Zuccatosta L, Papi A, Gasparini S, Marchetti G. Mei F, et al. BMC Pulm Med. 2023 Jul 10;23(1):252. doi: 10.1186/s12890-023-02530-4. BMC Pulm Med. 2023. PMID: 37430219 Free PMC article.
BACKGROUND: Pleural disease (PD), particularly malignant pleural effusion (MPE), is a common cause of hospital admission and its prevalence is rising worldwide. ...RESULTS: Ninety (23%) members replied, most of whom being pulmonologists (91%). MPE resu …
BACKGROUND: Pleural disease (PD), particularly malignant pleural effusion (MPE), is a common cause of hospital a …
Reducing hospital admissions in patients with malignant pleural effusion: a quality improvement study.
Cloyes RR, Josan E, Pastis N, Ma J, Palettas M, Peng J, Vasko-Wood S, Mohrman C, Ghattas C, Presley C, Revelo A, Pannu J. Cloyes RR, et al. BMJ Open Qual. 2023 Sep;12(3):e002197. doi: 10.1136/bmjoq-2022-002197. BMJ Open Qual. 2023. PMID: 37751941 Free PMC article. Review.
BACKGROUND: Malignant pleural effusions (MPE) can cause severe dyspnoea leading to greater than 125 000 hospitalisations per year and cost greater than US$5 billion per year in the USA. Timely insertion of tunnelled pleural catheters (TPCs) is associated with …
BACKGROUND: Malignant pleural effusions (MPE) can cause severe dyspnoea leading to greater than 125 000 hospitalisations per y …
Diagnostic method for malignant pleural effusion distinguishing malignant mesothelioma from lung cancer using pleural carcinoembryonic antigen and hyaluronic acid levels.
Saraya T, Ohkuma K, Fujiwara M, Ishii H. Saraya T, et al. Medicine (Baltimore). 2022 Jan 7;101(1):e28517. doi: 10.1097/MD.0000000000028517. Medicine (Baltimore). 2022. PMID: 35029914 Free PMC article.
Malignant mesothelioma (MM) is difficult to diagnose because of the lack of parenchymal opacities, often revealing minimal or absent pleural thickening. ...In general practice, lung cancer (LC) is the most common malignancy causing pleural effusion; th …
Malignant mesothelioma (MM) is difficult to diagnose because of the lack of parenchymal opacities, often revealing minimal or absent …
Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO. Dipper A, et al. Cochrane Database Syst Rev. 2020 Apr 21;4(4):CD010529. doi: 10.1002/14651858.CD010529.pub3. Cochrane Database Syst Rev. 2020. PMID: 32315458 Free PMC article.
BACKGROUND: Malignant pleural effusion (MPE) is a common problem for people with cancer and usually associated with considerable breathlessness. ...OBJECTIVES: To ascertain the optimal management strategy for adults with malignant pleural eff …
BACKGROUND: Malignant pleural effusion (MPE) is a common problem for people with cancer and usually associated with con …
Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis.
Yeung M, Loh EW, Tiong TY, Tam KW. Yeung M, et al. Clin Exp Metastasis. 2020 Aug;37(4):541-549. doi: 10.1007/s10585-020-10042-2. Epub 2020 Jun 10. Clin Exp Metastasis. 2020. PMID: 32524317
Malignant pleural effusion (MPE) results from primary mesothelioma or the spreading of metastatic cancer. Both talc pleurodesis (TP) and indwelling pleural catheter (IPC) improve MPE symptoms. We performed a meta-analysis of randomized controlled trial …
Malignant pleural effusion (MPE) results from primary mesothelioma or the spreading of metastatic cancer. Both talc ple …
Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
Fysh ETH, Waterer GW, Kendall PA, Bremner PR, Dina S, Geelhoed E, McCarney K, Morey S, Millward M, Musk AWB, Lee YCG. Fysh ETH, et al. Chest. 2012 Aug;142(2):394-400. doi: 10.1378/chest.11-2657. Chest. 2012. PMID: 22406960
BACKGROUND: Patients with malignant pleural effusion (MPE) have limited prognoses. They require long-lasting symptom relief with minimal hospitalization. Indwelling pleural catheters (IPCs) and talc pleurodesis are approved treatments for MPE. ...
BACKGROUND: Patients with malignant pleural effusion (MPE) have limited prognoses. They require long-lasting symptom re …
Management of the patient with a malignant pleural effusion.
Heffner JE. Heffner JE. Semin Respir Crit Care Med. 2010 Dec;31(6):723-33. doi: 10.1055/s-0030-1269831. Epub 2011 Jan 6. Semin Respir Crit Care Med. 2010. PMID: 21213204 Review.
A malignant pleural effusion (MPE) establishes an incurable stage of a malignancy. ...Treatment of MPE is moving toward less interventional approaches that can manage patients in ambulatory settings thereby decreasing cost, discomfort, and time away from home …
A malignant pleural effusion (MPE) establishes an incurable stage of a malignancy. ...Treatment of MPE is moving toward …
Malignant pleural effusion in the palliative care setting.
Arber A, Clackson C, Dargan S. Arber A, et al. Int J Palliat Nurs. 2013 Jul;19(7):320, 322-5. Int J Palliat Nurs. 2013. PMID: 24273808
Malignant pleural effusion (MPE) is a distressing condition for the patient, causing many symptoms such as shortness of breath, dry cough, an uncomfortable feeling of heaviness in the chest, and pleuritic pain. ...Treatment goals are concerned with the relief …
Malignant pleural effusion (MPE) is a distressing condition for the patient, causing many symptoms such as shortness of …
63 results